• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于真实世界数据的食管胃结合部 Siewert Ⅱ/Ⅲ型腺癌患者生存列线图的建立和验证。

Development and validation of a survival nomogram for patients with Siewert type II/III adenocarcinoma of the esophagogastric junction based on real-world data.

机构信息

Center for Gastrointestinal Surgery, the First Affiliated Hospital of Sun Yat-Sen University, 58 Zhongshan 2nd Road, Guangzhou, 510080, Guangdong, China.

Department of Obstetrics and Gynecology, the First Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong, China.

出版信息

BMC Cancer. 2021 May 10;21(1):532. doi: 10.1186/s12885-021-08249-x.

DOI:10.1186/s12885-021-08249-x
PMID:33971833
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8111941/
Abstract

BACKGROUND

The clinical staging systems for adenocarcinoma of the esophagogastric junction (AEG) are controversial. We aimed to propose a prognostic nomogram based on real-world data for predicting survival of Siewert type II/III AEG patients after surgery.

METHODS

A total of 396 patients with Siewert type II/III AEG diagnosed and treated at the Center for Gastrointestinal Surgery, the First Affiliated Hospital, Sun Yat-sen University, from June 2009 to June 2017 were enrolled. The original data of 29 variables were exported from the electronic medical records system. The nomogram was established based on multivariate Cox regression coefficients, and its performance was measured using Harrell's concordance index (C-index), receiver operating characteristic (ROC) curve analysis and calibration curve.

RESULTS

A nomogram was constructed based on nine variables. The C-index for overall survival (OS) prediction was 0.76 (95% CI, 0.72 to 0.80) in the training cohort, in the validation-1 cohort was 0.79 (95% CI, 0.72 to 0.86), and 0.73 (95% CI, 0.67 to 0.80) in the validation-2 cohort. Time-dependent ROC curves and calibration curves in all three cohorts showed good prognostic predictive accuracy. We further proved the superiority of the nomogram in predictive accuracy for OS to pathological TNM (pTNM) staging system and other independent prognostic factors. Kaplan-Meier survival curves demonstrated the pTNM stage, grade of differentiation, positive lymph node, log odds of positive lymph node and organ invasion were prognostic factors with good discriminative ability.

CONCLUSION

The established nomogram demonstrated a more precise prognostic prediction for patients with Siewert type II/III AEG.

摘要

背景

食管胃结合部腺癌(AEG)的临床分期系统存在争议。我们旨在基于真实世界的数据提出一个预测 Siewert Ⅱ/Ⅲ型 AEG 患者手术后生存的预后列线图。

方法

共纳入 2009 年 6 月至 2017 年 6 月中山大学附属第一医院胃肠外科诊治的 396 例 Siewert Ⅱ/Ⅲ型 AEG 患者,从电子病历系统中导出 29 个原始变量的数据。列线图基于多变量 Cox 回归系数建立,并使用 Harrell 一致性指数(C-index)、接收者操作特征(ROC)曲线分析和校准曲线来衡量其性能。

结果

基于 9 个变量构建了一个列线图。在训练队列中,总生存(OS)预测的 C-index 为 0.76(95%CI,0.72 至 0.80),在验证-1 队列中为 0.79(95%CI,0.72 至 0.86),在验证-2 队列中为 0.73(95%CI,0.67 至 0.80)。所有三个队列中的时间依赖性 ROC 曲线和校准曲线均显示出良好的预后预测准确性。我们进一步证明了该列线图在 OS 预测准确性方面优于病理 TNM(pTNM)分期系统和其他独立预后因素。Kaplan-Meier 生存曲线表明,pTNM 分期、分化程度、阳性淋巴结、阳性淋巴结对数优势和器官侵犯是具有良好判别能力的预后因素。

结论

建立的列线图为 Siewert Ⅱ/Ⅲ型 AEG 患者提供了更精确的预后预测。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0e14/8111941/e391eb39042c/12885_2021_8249_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0e14/8111941/5effaafea856/12885_2021_8249_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0e14/8111941/de64fac31168/12885_2021_8249_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0e14/8111941/ee908fad1eae/12885_2021_8249_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0e14/8111941/d865784596cb/12885_2021_8249_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0e14/8111941/e391eb39042c/12885_2021_8249_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0e14/8111941/5effaafea856/12885_2021_8249_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0e14/8111941/de64fac31168/12885_2021_8249_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0e14/8111941/ee908fad1eae/12885_2021_8249_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0e14/8111941/d865784596cb/12885_2021_8249_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0e14/8111941/e391eb39042c/12885_2021_8249_Fig5_HTML.jpg

相似文献

1
Development and validation of a survival nomogram for patients with Siewert type II/III adenocarcinoma of the esophagogastric junction based on real-world data.基于真实世界数据的食管胃结合部 Siewert Ⅱ/Ⅲ型腺癌患者生存列线图的建立和验证。
BMC Cancer. 2021 May 10;21(1):532. doi: 10.1186/s12885-021-08249-x.
2
Proposal of a Nomogram for Predicting Survival in Patients with Siewert Type II Adenocarcinoma of the Esophagogastric Junction After Preoperative Radiation.术前放疗后预测食管胃交界部 Siewert Ⅱ型腺癌患者生存的列线图的建立
Ann Surg Oncol. 2019 May;26(5):1292-1300. doi: 10.1245/s10434-019-07237-7. Epub 2019 Feb 25.
3
Prognostic nomogram for Siewert type II adenocarcinoma of the esophagogastric junction patients with and without neoadjuvant radiotherapy: a retrospective cohort study.食管胃交界部Siewert II型腺癌患者接受和未接受新辅助放疗的预后列线图:一项回顾性队列研究
Am J Transl Res. 2022 Jan 15;14(1):135-149. eCollection 2022.
4
Survival nomogram for patients with metastatic siewert type II adenocarcinoma of the esophagogastric junction: a population-based study.胃食管结合部 Siewert II 型腺癌转移患者的生存列线图:一项基于人群的研究。
Expert Rev Gastroenterol Hepatol. 2020 Aug;14(8):757-764. doi: 10.1080/17474124.2020.1784726. Epub 2020 Jun 30.
5
Nomograms for Predicting Disease-Free Survival in Patients With Siewert Type II/III Adenocarcinoma of the Esophagogastric Junction Receiving Neoadjuvant Therapy and Radical Surgery.用于预测接受新辅助治疗和根治性手术的食管胃交界部Siewert II/III型腺癌患者无病生存期的列线图
Front Oncol. 2022 Jun 8;12:908229. doi: 10.3389/fonc.2022.908229. eCollection 2022.
6
[Clinical implications of Naples prognostic scores in patients with resectable Siewert type II-III adenocarcinoma of the esophagogastric junction].[那不勒斯预后评分对可切除的食管胃交界部Siewert II-III型腺癌患者的临床意义]
Zhonghua Wei Chang Wai Ke Za Zhi. 2024 Jan 25;27(1):54-62. doi: 10.3760/cma.j.cn441530-20230319-00084.
7
[Survival comparison of Siewert II adenocarcinoma of esophagogastric junction between transthoracic and transabdominal approaches:a joint data analysis of thoracic and gastrointestinal surgery].[经胸与经腹入路治疗食管胃交界部Siewert II型腺癌的生存比较:胸外科与胃肠外科联合数据分析]
Zhonghua Wei Chang Wai Ke Za Zhi. 2019 Feb 25;22(2):132-142.
8
Clinicopathological features and prognostic factors of adenocarcinoma of the esophagogastric junction according to Siewert classification: experiences at a single institution in Japan.根据 Siewert 分类的食管胃结合部腺癌的临床病理特征和预后因素:日本单机构经验。
Ann Surg Oncol. 2012 Feb;19(2):677-83. doi: 10.1245/s10434-011-1983-x. Epub 2011 Aug 6.
9
Construction of a novel nomogram for predicting overall survival in patients with Siewert type II AEG based on LODDS: a study based on the seer database and external validation.基于LODDS构建预测Siewert II型AEG患者总生存期的新型列线图:一项基于SEER数据库及外部验证的研究
Front Oncol. 2024 Jun 7;14:1396339. doi: 10.3389/fonc.2024.1396339. eCollection 2024.
10
Nomogram predicted survival of patients with adenocarcinoma of esophagogastric junction.列线图预测食管胃交界腺癌患者的生存率。
World J Surg Oncol. 2015 Jun 10;13:197. doi: 10.1186/s12957-015-0613-7.

引用本文的文献

1
Prognostic significance of an innovative staging system based on the logarithmic odds of positive lymph nodes for resectable gastroesophageal cancer after neoadjuvant chemoradiation: a population-based study with external validation of data.基于对数阳性淋巴结比值的创新分期系统对新辅助放化疗后可切除胃食管交界癌预后意义的研究:基于人群的研究及数据外部验证
J Transl Med. 2024 Aug 29;22(1):801. doi: 10.1186/s12967-024-05448-5.
2
Nomograms for prognosis prediction in esophageal adenocarcinoma: realities and challenges.食管腺癌预后预测的列线图:现状与挑战
Clin Transl Oncol. 2025 Feb;27(2):449-457. doi: 10.1007/s12094-024-03589-z. Epub 2024 Jul 31.
3

本文引用的文献

1
Personalized four-category staging for predicting prognosis in patients with small bowel Adenocarcinoma: an international development and validation study.个性化四分类分期预测小肠腺癌患者预后:一项国际开发和验证研究。
EBioMedicine. 2020 Oct;60:102979. doi: 10.1016/j.ebiom.2020.102979. Epub 2020 Sep 24.
2
Predicting distant metastasis and chemotherapy benefit in locally advanced rectal cancer.预测局部进展期直肠癌的远处转移和化疗获益。
Nat Commun. 2020 Aug 27;11(1):4308. doi: 10.1038/s41467-020-18162-9.
3
Superiority of log odds of positive lymph nodes (LODDS) for prognostic prediction after gastric cancer surgery: a multi-institutional analysis of 7620 patients in China.
Risk, Predictive Factors, and Nomogram of Liver Metastatic Gastroesophageal Junction Cancer: A New Study Based on the Surveillance, Epidemiology, and End Results Database.
肝转移胃食管交界癌的风险、预测因素及列线图:一项基于监测、流行病学和最终结果数据库的新研究
Cureus. 2024 Jun 28;16(6):e63429. doi: 10.7759/cureus.63429. eCollection 2024 Jun.
4
Development of a novel staging classification for Siewert II adenocarcinoma of the esophagogastric junction after neoadjuvant chemotherapy.新辅助化疗后食管胃交界部Siewert II型腺癌新型分期分类的制定
World J Gastrointest Oncol. 2024 Jun 15;16(6):2541-2554. doi: 10.4251/wjgo.v16.i6.2541.
5
Development and validation of a nomogram for Siewert II esophagogastric junction adenocarcinoma: a retrospective analysis.Siewert II型食管胃交界腺癌列线图的开发与验证:一项回顾性分析
Ther Adv Med Oncol. 2024 Feb 4;16:17588359241229425. doi: 10.1177/17588359241229425. eCollection 2024.
6
Marital Status Is a Prognostic Factor for Cardiovascular Mortality but Not a Prognostic Factor for Cancer Mortality in Siewert Type II Adenocarcinoma of the Esophagogastric Junction.婚姻状况是食管胃交界部Siewert II型腺癌患者心血管疾病死亡率的预后因素,但不是癌症死亡率的预后因素。
Gastroenterology Res. 2023 Dec;16(6):307-317. doi: 10.14740/gr1670. Epub 2023 Dec 9.
7
Neural network-based prognostic predictive tool for gastric cardiac cancer: the worldwide retrospective study.基于神经网络的贲门癌预后预测工具:全球回顾性研究
BioData Min. 2023 Jul 18;16(1):21. doi: 10.1186/s13040-023-00335-z.
8
Nomogram for predicting the likelihood of liver metastases at initial diagnosis in patients with Siewert type II gastroesophageal junction adenocarcinoma.预测 Siewert Ⅱ型胃食管结合部腺癌患者初始诊断时肝转移可能性的列线图。
Sci Rep. 2023 Jul 7;13(1):11032. doi: 10.1038/s41598-023-37318-3.
9
A novel nomogram based on clinical blood indicators for prognosis prediction in curatively resected esophagogastric junction adenocarcinoma patients.一种基于临床血液指标的新型列线图,用于预测接受根治性切除的食管胃交界腺癌患者的预后。
J Cancer. 2023 May 21;14(9):1553-1561. doi: 10.7150/jca.83588. eCollection 2023.
10
Model established based on blood markers predicts overall survival in patients after radical resection of types II and III adenocarcinoma of the esophagogastric junction.基于血液标志物建立的模型可预测食管胃交界部II型和III型腺癌根治术后患者的总生存期。
World J Gastrointest Surg. 2022 Aug 27;14(8):788-798. doi: 10.4240/wjgs.v14.i8.788.
胃癌手术后淋巴结阳性对数优势(LODDS)对预后预测的优越性:中国 7620 例患者的多机构分析。
Surg Today. 2021 Jan;51(1):101-110. doi: 10.1007/s00595-020-02091-7. Epub 2020 Aug 4.
4
Identification of the distinct genomic features in gastroesophageal junction adenocarcinoma and its Siewert subtypes.胃食管结合部腺癌及其 Siewert 亚型的独特基因组特征的鉴定。
J Pathol. 2020 Nov;252(3):263-273. doi: 10.1002/path.5516. Epub 2020 Oct 2.
5
Survival nomogram for patients with metastatic siewert type II adenocarcinoma of the esophagogastric junction: a population-based study.胃食管结合部 Siewert II 型腺癌转移患者的生存列线图:一项基于人群的研究。
Expert Rev Gastroenterol Hepatol. 2020 Aug;14(8):757-764. doi: 10.1080/17474124.2020.1784726. Epub 2020 Jun 30.
6
Factors Affecting Sentinel Node Metastasis in Thin (T1) Cutaneous Melanomas: Development and External Validation of a Predictive Nomogram.影响薄型(T1)皮肤黑色素瘤前哨淋巴结转移的因素:预测列线图的开发与外部验证
J Clin Oncol. 2020 May 10;38(14):1591-1601. doi: 10.1200/JCO.19.01902. Epub 2020 Mar 13.
7
Validation of nomogram-revised risk index and comparison with other models for extranodal nasal-type NK/T-cell lymphoma in the modern chemotherapy era: indication for prognostication and clinical decision-making.在现代化疗时代,列线图修订风险指数的验证及其与其他模型在结外鼻型 NK/T 细胞淋巴瘤中的比较:预后和临床决策的指征。
Leukemia. 2021 Jan;35(1):130-142. doi: 10.1038/s41375-020-0791-3. Epub 2020 Mar 9.
8
Involvement of Platelets in Cancers.血小板与癌症的关系。
Semin Thromb Hemost. 2019 Sep;45(6):569-575. doi: 10.1055/s-0039-1693475. Epub 2019 Aug 5.
9
Gastroesophageal Junction Adenocarcinoma: Is There an Optimal Management?胃食管交界腺癌:是否存在最佳治疗方案?
Am Soc Clin Oncol Educ Book. 2019 Jan;39:e88-e95. doi: 10.1200/EDBK_236827. Epub 2019 May 17.
10
Optimal management of gastroesophageal junction cancer.胃食管结合部癌的最佳治疗管理。
Cancer. 2019 Jun 15;125(12):1990-2001. doi: 10.1002/cncr.32066. Epub 2019 Apr 11.